产品名称 | NebuSelect™ Recombinant Human B7-H4, Avi-His-tag |
---|---|
目录号 | NBL-243034 |
别名 | B7-H4; B7H4; B7-H4; B7S1; B7h.5; B7x; FLJ22418; VTCN1; PRO1291 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q7Z7D3-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-243034-100ug | 100ug | Inquire | Inquire | |
NBL-243034-1mg | 1mg | Inquire | Inquire | |
NBL-243034-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human B7-H4, Avi-His-tag
Catalog#:
NBL-243034
Description:
NebuSelect™ Recombinant Human B7-H4, Avi-His-tag(Cat#NBL-243034) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Phe29-Ala258.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 28.2 kDa. Due to glycosylation, the protein migrates to 52-68 kDa based on Bis-Tris PAGE result.
Target Name:
B7-H4; B7H4; B7-H4; B7S1; B7h.5; B7x; FLJ22418; VTCN1; PRO1291
Target Information:
B7-H4, also known as B7x and B7S1, is a 50-80 kDa glycosylated member of the B7 family of immunomodulatory proteins. B7-H4 is up-regulated in several carcinomas in correlation with tumor progression and metastasis. A soluble form of B7-H4 is elevated in the serum of ovarian cancer, renal cell carcinoma, and rheumatoid arthritis patients, also in correlation with advanced disease status-.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.